FawkesBlog

How Patient-Owned Medical Data Could Decentralize Healthcare Giants and Revolutionize Care Through AI

Published by Ian Taylor on September 23, 2024

The health tech landscape is rapidly transforming, with artificial intelligence (AI) emerging as a driving force in the way we deliver ... Read More

23andMe board resigns...time to change the business model of patient data

Published by Ian Taylor on September 19, 2024

In a surprising turn of events, the board of 23andMe has resigned en masse, raising questions about the company’s future direction and its underlying business model. At the center of this shake-up is CEO Anne Wojcicki, who appears to be navigating a delicate transition—attempting to t... Read More

The Bursting Bubble of AI-Driven Biotech and Pharma: Promises and Emerging Challenges

Published by Ian Taylor on September 17, 2024

Artificial Intelligence (AI) in biotechnology and pharmaceuticals was poised to reshape innovation and tailor healthcare soluti... Read More

Fighting Patient Fatigue in Clinical Trials: A Call for Smarter Data Collection

Published by Ian Taylor on September 12, 2024

Clinical trials are the backbone of medical breakthroughs, but a rising challenge puts their success at risk: patient fatigue in data collection. As trials become more high-tech and decentralized, participants are being asked to track more and more data. This constant reporting is wearing patient... Read More

Challenges and Opportunities in AI-Based Drug Development

Published by Ian Taylor on September 09, 2024

The pharmaceutical industry is witnessing a transformative shift with the integration of artificial intelligence (AI) in drug development. AI has the potential to revolutionize the entire drug discovery and development process by improving efficiency, reducing costs, and accelerating time-to-mark... Read More